To update the National Action Plan for Adverse Drug Event Prevention to consider advances in pharmacogenomic research and testing, to improve electronic health records for pharmacogenomic information, and for other purposes.
About This Bill
Committee
Latest Action · March 29, 2024
Referred to the House Committee on Energy and Commerce.